Clinical trial
The Effect of Intra-articular Injection of Betamethasone Acetate/Betamethasone Sodium Phosphate at the Knee Joint on the Hypothalamic-pituitary-adrenal Axis: a Case Controlled Study
NCT01799408 is registered in ClinicalTrials.gov with The Nazareth Hospital, Israel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Intra-articular Injection of Betamethasone Acetate/Betamethasone Sodium Phosphate at the Knee Joint on the Hypothalamic-pituitary-adrenal Axis: a Case Controlled Study
- Lead sponsor
- The Nazareth Hospital, Israel
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- February 28, 2013
- Enrollment
- 40 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
adrenal suppression